Skip to content

Are you in a crisis? Call or text 988 or text TALK to 741741

¿Estás en una crisis? Llama o envía un mensaje de texto al 988 o envía un mensaje de texto con AYUDA al 741741

Ketamine in Borderline Personality Disorder

2017 Young Investigator Grant

Amount Awarded: $84,995

Focus Area: Clinical Treatment Studies

Sarah Fineberg, M.D., Ph.D.

Sarah Fineberg, M.D., Ph.D.

Yale University

Inside the Research

Question: Is ketamine a viable treatment for people with suicidal ideation and Borderline Personality Disorder (BPD)?

Strategy: Sixty-six 21-30 year olds with BPD and suicidal ideation will participate in this double-blind placebo-controlled trial of low vs. high dose IV ketamine vs. midazolam.

Impact: An intervention for suicidal ideation among people with BPD.